… founding MJFF Board member Fred Weiss has been asking him to write down his children’s stories. In 2013, he finally … Board since 2000, and an advocate for the Parkinson’s community even longer, Fred first met Michael J. Fox while … Foundation, he says, has evolved immensely over the years. However, he is struck by MJFF’s “focus with a clear …

… Thus, inhibition of calpain using selective, targeted inhibitors which cross the blood brain barrier and can be … diseases and calpain inhibitors have been shown to be potentially effective as therapeutic agents in a … a legitimate target in the prevention of PD. Anticipated Outcome: It is anticipated that in this initial investigation …

… The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark … to accelerate this process through a concerted effort to combine resources and expertise from several different … Alzheimer's disease research, leading to insights on how that pathology leads to cognitive decline. PD …

… Home Page Cancel Register for Webinar What Ever Happened to Stem Cells? First Name   Last Name   Email   Postal Code … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … cells (embryonic and induced pluripotent stem cells) and how researchers are using these tools to learn more about …

… submission. Home Page Cancel Register for Webinar The Path to a Parkinson's Drug Approval First Name   Last Name   … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … therapeutic pipeline and what it takes for a treatment to get FDA approval and become available to patients. Join us …

… Darcy Blake is the Director of Communications, Public Relations, Marketing for Menlo … a day, and PD progression won't be either. But what about HOW you take that breath? If you don't know what that means, …